Ketamine Completed Phase 4 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03149991A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
NCT01306760The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy